Sponsor Pipeline

Dr. Md. Alimur Reza Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
1
Disease Areas
4
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-05 NCT06804096
Efficacy and Safety of Faropenem in Bangladeshi Adult Patients With Community-Acquired…
Trial completed
2026-08-05 NCT06804096
Efficacy and Safety of Faropenem in Bangladeshi Adult Patients With Community-Acquired…
Enrollment reduced: 160 -> 129 participants
2026-08-05 NCT06804096
Efficacy and Safety of Faropenem in Bangladeshi Adult Patients With Community-Acquired…
date change Primary completion pushed: 2025-09-30 -> 2026-01-12
2026-08-05 NCT06804096
Efficacy and Safety of Faropenem in Bangladeshi Adult Patients With Community-Acquired…
date change Completion pushed: 2025-12-01 -> 2026-01-26
Active Trials by Phase
Phase 4
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT06789432 Efficacy and Safety of Atorvastatin and Ezetimibe (10/10mg) Fixed Dose Combination Versus… Hyperlipidemia (E.G., Hypercholesterolemia) Recruiting
Not specified
NCT07099742 Effectiveness and Safety of Tirzepatide Among Participants With Obesity With or Without… Obesity Not Yet Recruiting
Disease Areas
Get alerts when Dr. Md. Alimur Reza's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free